Table 3.
AV access outcome | Definition |
---|---|
Access primary failure | Permanent failure of the fistula or graft before hemodialysis suitability. This includes inadequate maturation, thrombosis, failure of first and subsequent cannulations, and other complications leading to nonfunctional fistula or graft. |
Successful cannulation | The AV access became the primary vascular access for hemodialysis (the fistula or graft access has been cannulated with two 16- or 15-gauge needles for ≥3 consecutive dialysis sessions and the TCVC was removed). |
Suitability for hemodialysis | Fistula or graft use with two needles and maintenance of blood flow ≥300 ml/min for ≥75% of dialysis sessions over a continuous 4-week. The maturation criteria can be satisfied at any time within 6 months of fistula or graft creation surgery. |
Unassisted access maturation | Criteria for fistula or graft suitable for hemodialysis (based on the above criteria) are met before any endovascular or secondary surgical procedure to facilitate maturation. |
Assisted access maturation | Satisfaction of the criteria for fistula or graft suitability for hemodialysis after a procedure to facilitate maturation (e.g., angioplasty, stent placement, surgical revision, ligation of accessory veins). |
Access primary patency | Procedure-free access survival defined as the time from index fistula or graft creation to the first of one of the following events: access thrombosis; any procedure designed to facilitate, maintain, or re-establish patency. |
Access assisted primary patency | Interval of time from index fistula or graft creation until the first of one of the following events: access thrombosis, censoring event, or study end. This period includes all procedures (surgical or endovascular) designed to maintain the functionality of the dialysis vascular access as long as access patency was not lost. |
Access cumulative patency | Interval of time from index fistula or graft creation until access abandonment, censoring event, or study end. This period include access primary patency period and access assisted primary patency period. |
Post-procedure primary patency | Interval of time from the first procedure designed to maintain the functionality of the index dialysis vascular access until the first of one of the following events: access thrombosis; any procedure designed to facilitate, maintain, or re-establish patency; censoring event; or study end. |
Noninfectious complications | Stenosis, thrombosis, hand ischemia, aneurysm, pseudoaneurysm, infiltration. |
Infectious complications | Fistula or graft cellulitis, abscess, bacteremia. |
Access procedures | Angioplasty, stent placement, surgical revision, ligation of accessory veins, superficialization of vein. |
Other clinical outcomes | TCVC placement, new AV access surgical creation, AV access–related hospitalization or death. |
Limb ischemia following AV access placement | |
Symptoms | Paresthesia, pain, hand stiffness, ulceration and tissue loss in the limb with AV access. |
Physical examination | Diminished or absent radial pulse, pallor, diminished sensation, and, in advanced stages or severe cases, ulceration and gangrene. |
Grade 1, mild | Cool extremity with few symptoms but steal demonstrable by flow augmentation with access occlusion. |
Grade 2, moderate | Intermittent ischemia only during dialysis/claudication. |
Grade 3, severe |
Ischemic pain at rest/tissue loss. |
TCVC access outcome |
Examples |
Infectious complications | Catheter exit site infection, tunnel infection, bacteremia. |
Non-infectious complications | Catheter malposition, mechanical dysfunction, catheter migration, venous thrombosis, pneumothorax, heamothorax, arterial puncture. |
Abbreviations: AV, arteriovenous; TCVC, tunneled central venous catheter.